Press Releases

Formulationbio Newly Launches Disintegrant Excipients for Pharmaceutical Preparation

ENPICOM and Viroclinics-DDL receive joint MIT Zuid subsidy to accelerate and improve antibody and vaccine discovery and development

ENPICOM BV, an innovative bioinformatics software engineering company, has announced the approval of a joint MIT Zuid subsidy (SME Innovation Stimulation Top Sectors South Holland) application with Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development.

BOC Sciences Provides Extensive Catalog of Building Blocks

Thermo Fisher Scientific Collaborates with Artificial to Enhance COVID-19 Diagnostic Testing Solution

Thermo Fisher Scientific, which today announced their collaboration with Artificial to increase the productivity of COVID-19 testing through an integrated and comprehensive software automation platform.

Creative Biostructure Provides Various Vaccine Development Services for Coronavirus

Profacgen Provides Immunogenicity Testing Services to Help with Drug Discovery and Development

SignalChem Enters a Clinical Trial Collaboration with Merck to Evaluate the Effect of SLC-391 in Combination with KEYTRUDA® (pembrolizumab) in Advanced Non-Small Cell Lung Cancer

SignalChem Lifesciences, a clinical-stage company developing novel targeted therapies for oncology, has announced a collaboration with Merck, through a subsidiary, to evaluate the combination of SLC-391, a selective AXL inhibitor developed by SignalChem, with KEYTRUDA®, Merck’s anti-PD-1 therapy, in patients with advanced non-small cell lung cancer (NSCLC).

CluePoints Sponsors RBQM Live

Panthera is running a Ph 3 trial for AstraZeneca’s monoclonal antibody combination to reduce the effects of COVID-19 in patients with the virus from its North Manchester site

Panthera is enrolling Covid patients for AstraZeneca’s monoclonal antibody study to reduce disease severity

THREAD and Lokavant Partner to Provide Sponsors with First DCT Benchmarking Solution

THREAD and Lokavant partner

Alfa Chemistry Catalysts Launches Catalysts for Olefin Metathesis Reaction

MicrobioSeq Releases Microecology and Cancer Solutions to Accelerate Your Cancer Research and Discovery

FDA Grants Orphan Drug Designation for Shylicine™

Vanessa Biotech has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the drug Shylicine™

Science 37® and Xperiome™ Partner to Increase the Efficiency and Speed of Rare Disease Studies for Patients and Providers

Matexcel Offers a Comprehensive List of Graphene Products

Vanessa Research is now Vanessa Biotech

Continuous manufacturing μLOT® enabling technology could cut pharma industry’s use of toxic chemicals by one hundred times

Speaking at the ‘Innovative Chemistry for Peptide Manufacturing and Analysis’ conference, SB3000’s Chief R&D Officer Jens Bukrinski revealed that continuous manufacturing μLOT® technology could reduce the pharmaceutical industry’s use of toxic chemicals by 100 times.

Ceryx Medical appoints Chas Taylor as Chairman

Ceryx Medical, the business behind a revolutionary technology that could significantly change the way patients with serious heart problems are treated, has appointed Chas Taylor, a leading medical devices entrepreneur, as Chairman.

COPD Foundation and DevPro Biopharma Join Forces to Develop Treatments for People with COPD and Related Lung Conditions

COPD Foundation and DevPro Biopharma enter into a strategic alliance to develop more effective treatments for people with chronic lung conditions and get them to patients sooner.

CD BioSciences is Ready to Provide Clinical Data Management Service

CD BioSciences, a US based supplier of one-stop clinical trial services, has announced to provide global scientists with clinical data management, analysis and reporting service.